Woodline Partners’s Jasper Therapeutics JSPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-245,676
| Closed | -$5.25M | – | 970 |
|
2024
Q4 | $5.25M | Sell |
245,676
-249,428
| -50% | -$5.33M | 0.04% | 477 |
|
2024
Q3 | $9.31M | Buy |
495,104
+81,164
| +20% | +$1.53M | 0.08% | 308 |
|
2024
Q2 | $9.4M | Buy |
413,940
+34,694
| +9% | +$788K | 0.09% | 253 |
|
2024
Q1 | $11.1M | Buy |
379,246
+205,947
| +119% | +$6.05M | 0.1% | 246 |
|
2023
Q4 | $1.37M | Sell |
173,299
-126,701
| -42% | -$1,000K | 0.01% | 391 |
|
2023
Q3 | $2.1M | Hold |
300,000
| – | – | 0.02% | 395 |
|
2023
Q2 | $4.11M | Hold |
300,000
| – | – | 0.05% | 320 |
|
2023
Q1 | $5.43M | Buy |
+300,000
| New | +$5.43M | 0.07% | 284 |
|